Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onset of platelet aggregation inhibition with ACT-246475 in acute myocardial infarction
2018-000765-36Phase 2Completed
- Sponsor
- Idorsia
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of selatogrel in myocardial infarction (MI), sponsored by Idorsia. Started May 2018; status: completed.
02
Drugs
selatogrel
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2018-000765-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000765-36.